Penghua CSI Chinese Medicine ETF (159647) rises 2.55%, with a net inflow of 30.8254 million yuan for ten consecutive days

NewTimeSpace (newtimespace.com) News, as of 14:25 on May 29, 2026, Penghua Traditional Chinese Medicine ETF (159647) rose 2.55%, with the latest price at 0.89 yuan. (The stocks listed above are only index constituents and do not constitute any specific recommendation.)

In terms of liquidity, Penghua Traditional Chinese Medicine ETF recorded an intraday turnover rate of 2.38% and a trading volume of 33.7613 million yuan. Over a longer time frame, as of May 28, the ETF's average daily trading volume over the past year reached 30.3455 million yuan.

In terms of scale, Penghua Traditional Chinese Medicine ETF saw a significant increase of 668 million yuan in scale over the past year, with the new scale increase ranking 1/4 among comparable funds. (Data source: Wind)

In terms of shares, the latest share count of Penghua Traditional Chinese Medicine ETF reached 1.614 billion units, hitting a one-year high and ranking 2/4 among comparable funds. (Data source: Wind)

In terms of net capital inflow, Penghua Traditional Chinese Medicine ETF saw consecutive net inflows for ten days, with the highest single-day net inflow reaching 6.9423 million yuan. It attracted a total of 30.8254 million yuan, with an average daily net inflow of 3.0825 million yuan. (Data source: Wind)

Data shows that leveraged funds are continuously positioning. Penghua Traditional Chinese Medicine ETF has seen net purchases by leveraged funds for four consecutive days, with the highest single-day net purchase reaching 3.4108 million yuan. The latest margin financing balance stood at 26.2531 million yuan. (Data source: Wind)

From the perspective of return capability, as of May 28, 2026, since its inception, Penghua Traditional Chinese Medicine ETF achieved a highest single-month return of 16.26%, a longest streak of consecutive up months of 5 months, a maximum cumulative gain during that streak of 20.28%, and an average return of 4.98% in up months. As of May 28, 2026, the ETF's annualized excess return over its benchmark for the past two years was 2.58%, ranking 1/4 among comparable funds.

In terms of drawdown, as of May 28, 2026, Penghua Traditional Chinese Medicine ETF recorded a drawdown of 0.06% relative to its benchmark since the beginning of the year, the smallest drawdown among comparable funds.

In terms of fees, Penghua Traditional Chinese Medicine ETF has a management fee rate of 0.50% and a custodian fee rate of 0.10%, the lowest fee rates among comparable funds.

In terms of tracking accuracy, as of May 28, 2026, the one-year tracking error of Penghua Traditional Chinese Medicine ETF was 0.043%, achieving the highest tracking accuracy among comparable funds.

From a valuation perspective, the latest price-to-earnings (PE-TTM) ratio of the CSI Traditional Chinese Medicine Index, which Penghua Traditional Chinese Medicine ETF tracks, is only 20.96 times, standing at the 0.39% percentile over the past year. This means the valuation is lower than over 99.61% of the time in the past year, placing it at a historical low.

Penghua Traditional Chinese Medicine ETF closely tracks the CSI Traditional Chinese Medicine Index. The CSI Traditional Chinese Medicine Index selects the securities of listed companies whose businesses involve the production and sale of traditional Chinese medicine as index constituents, in order to reflect the overall performance of traditional Chinese medicine concept listed companies.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.